Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 4 November 2026.
Announcements
6,263
Total raised
£165B
disclosed amounts
This month
£177M
raised so far
The seed round was backed by high-profile investors including Matthew Freud, Jonnie Goodwin and Rhys Oldfield.
"I knew immediately I would invest. Tendering made a huge difference to Be At One. EzTenda gives every operator access to the marketing budgets available from every brand, big and small. Whether it be house pour or back-bar, it’s a no-brainer."
Highland Europe led the $24m investment, which values the plant-based food brand at $560m.
"I’ve been a Hueligan for several years now, starting my journey while preparing for my role in Thor, so to come on board with Huel was an easy decision. I believe in their mission to deliver nutritionally complete food, sustainably. We have some exciting projects coming up and I look forward to spreading the message and raising awareness around healthy, low carbon food."
The investment was co-led by Novum Capital Partners and Fifth Wall to support international expansion and product development.
"From the first meeting, we were completely bought into Vivi and Karolina’s vision. AltoVita is one of the most capital efficient operations that I’ve seen in many years and the growth AltoVita has achieved is rare, particularly within the current market challenges. The company brings a truly unique offering to the corporate travel market and we couldn’t be happier to see the progress that the team has made over the past year. Our recent investment will give AltoVita the firepower to scale its vision into new markets, and continue to develop its seamless solution for the fragmented corporate accommodation sector."
The Bristol-based biotech start-up has closed its pre-seed round ahead of commercial production and launch.
"There is so much biological information that could enable early intervention for healthcare, but no route to clear access. The menstrual cycle is a non-invasive route to giving our users better health data for better health outcomes,. Many health conditions are difficult for researchers to analyse at the moment because they require invasive testing or regular monitoring which is inconvenient, time-intensive and often uncomfortable. Emm has the potential to do this in a practical, painless way."
The funding round was supported by Oxford Innovation EIS Growth Fund and OION Angels.
"This new funding allows EcoSync to make significant progress towards the next milestones in its development strategy, giving us the opportunity to expand into other sectors and accelerate growth. Without the support of our new, and existing, investors we would not have been able to make such compelling advancements and take our solution to market, where it can have a real impact in driving a transition towards net zero carbon."
